London, May 16, 2026, 23:03 (BST)
London’s market is closed for the weekend, but Tate & Lyle will return to screens Monday as a bid stock. The shares closed Friday at 536p, up about 45% from the previous Friday’s 370.8p close, after a sudden rally around U.S. peer Ingredion’s approach.
That is the point now. Ingredion’s proposal values Tate & Lyle at up to 615p a share, leaving the stock almost 15% below the possible takeout value. That gap is the bid spread — the discount traders leave when they think a deal may still fail, change price, or take time.
Tate & Lyle said shareholders would receive 595p in cash plus the right to receive up to 20p in dividends, made up of a final dividend of as much as 13p and an interim dividend of as much as 7p. The company said its board and Ingredion were in talks, but added there was “no certainty” that any offer would be made. Tate Lyle
Ingredion has also said discussions and due diligence are continuing. Under the UK Takeover Code, it has until 5 p.m. London time on June 11 to make a firm offer or walk away, a deadline often called “put up or shut up” in London deal markets. SEC
The move stood out because the tape was poor. Reuters reported Friday that the FTSE 100 had its biggest one-day drop in more than eight weeks, while the mid-cap FTSE 250 lost 1% and both indexes posted weekly losses as politics, rising oil and inflation worries hit UK assets.
The competitive logic is not hard to see. Barclays analyst Alex Sloane told the Financial Times there was “significant overlap” between Ingredion and Tate & Lyle, especially in sweeteners and starches, the sort of overlap that can support cost savings but can also invite scrutiny. Financial Times
Ingredion’s own investors were cooler. Reuters said Tate & Lyle surged as much as 55% when the approach emerged, while Ingredion shares dipped 2.8%; the report also said a deal could create a $10 billion food-ingredients group.
Tate & Lyle is no longer the old sugar refiner investors used to know. Reuters’ company profile describes it as a specialty food and beverage ingredients group, selling sweeteners, fibres, stabilisers, hydrocolloids, starches and other products across the Americas, EMEA and Asia Pacific.
The risk is simple and still live. This is not a binding bid. If due diligence throws up problems, if the board and bidder cannot settle on terms, or if regulators see too much overlap, the shares could give back part of the deal premium and trade again on demand, margins and integration questions rather than takeover arithmetic.
Next week brings a second test. Tate & Lyle is due to report fiscal 2026 results on May 21, with CEO Nick Hampton and CFO Sarah Kuijlaars scheduled to present at 0930 BST; investors will watch for any steer on the bid, the CP Kelco combination, top-line growth and the dividend plan.
For now, Friday’s close says the market believes a deal is possible, not done. That is a narrow but important difference.
